• en
    • he
    • ru
Home » Insights » Transactions » Therapix Biosciences

Therapix Biosciences

03.03.2017 | IPO

 ZAG-S&W represented Therapix Biosciences in $13.8 Million Initial Public Offering

Therapix is a specialty clinical-stage pharmaceutical company focused on technologies and assets based on cannabinoid pharmaceuticals.

The ZAG-S&W team consisted of attorneys from Boston, New York and Tel Aviv, including Howard Berkenblit, Oded Har-Even and David Huberman, as well as Shy Baranov, Rob Condon, Ron Ben-Bassat, Boaz Shiffman, Adi Israel and Hila Nahum represented them in this initial offering.

Recent Activity

All Media
This Media article belongs to the category: Transactions The article was published in the 24th December 2019.

Article title: On Track Innovations
This Media article belongs to the category: News The article was published in the 17th December 2019. | Jerusalem Post

Article title: Expert: Timing Key for US Expansion
This Media article belongs to the category: Events The article was published in the 08th September 2019. | New York City

Article title: Israeli-American Council (IAC) EDGE Summit
This Media article belongs to the category: Publications The article was published in the 15th May 2019. | The Jerusalem Post

Article title: Israeli Startups, IPO’s and Beyond
This Media article belongs to the category: News The article was published in the 16th April 2019. | ZAG-S&W

Article title: IVC Research Center and ZAG Report: Israeli High-Tech Companies Raised $1.55 Billion in 128 Deals in Q1/2019
This Media article belongs to the category: Publications The article was published in the 28th February 2019. | Zurich

Article title: Israeli Life Sciences Cluster: Promises for Global Stakeholders
This Media article belongs to the category: Transactions The article was published in the 12th February 2019. | Public Offering

Article title: Oppenheimer
This Media article belongs to the category: News The article was published in the 09th January 2019. | IVC Research Center

Article title: IVC | ZAG High-Tech Capital Raising Report: 2018 Marks All-Time Record as Israeli High-Tech Companies Raise $6.4 Billion in 623 Deals
This Media article belongs to the category: Transactions The article was published in the 14th May 2018. | TASE

Article title: IceCure Ltd.
This Media article belongs to the category: News The article was published in the 24th October 2017. | Globes

Article title: The quarterly research report of ZAG and IVC-Research Center was published
This Media article belongs to the category: Transactions The article was published in the 18th October 2017. | NASDAQ

Article title: Radcom Ltd.
This Media article belongs to the category: Transactions The article was published in the 12th September 2017. | NASDAQ

Article title: Alcobra Ltd.
This Media article belongs to the category: Transactions The article was published in the 15th June 2017. | NASDAQ

Article title: Foresight Autonomous Holdings Ltd.
This Media article belongs to the category: Transactions The article was published in the 15th May 2017. | Fundraising

Article title: BiomX Ltd.
This Media article belongs to the category: Events The article was published in the 12th March 2017. | Dana Point, California

Article title: ZAG is proud to be a Silver Sponsor of the 29th Annual ROTH Conference